title: Successful use of alemtuzumab in a child with refractory peripheral T-cell posttransplant lymphoproliferative disorder.
authors.affiliation: Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
authors.forename: Sandip
authors.initials: S
authors.lastname: Bartakke
authors.forename: Oussama
authors.initials: O
authors.lastname: Abla
authors.forename: Sheila
authors.initials: S
authors.lastname: Weitzman
mesh_terms: D000074323:Alemtuzumab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm / Q000627:therapeutic use*; D005260:Female; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D007223:Infant; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000209:etiology; D013601:T-Lymphocytes
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000912:Antibodies, Neoplasm; D000074323:Alemtuzumab